FDA Approves Emrosi for Rosacea in Adults

TUESDAY, Nov. 12, 2024-- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.The extended-release capsules (40 mg) will be available late in the first quarter or...